Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure
about
Stanniocalcin-1 regulates extracellular ATP-induced calcium waves in human epithelial cancer cells by stimulating ATP release from bystander cellsNovel functional view of the crocidolite asbestos-treated A549 human lung epithelial transcriptome reveals an intricate network of pathways with opposing functionsCharacterization of stanniocalcin 2, a novel target of the mammalian unfolded protein response with cytoprotective propertiesDeletion of the miR-143/145 cluster leads to hydronephrosis in miceStanniocalcin1 is a key mediator of amyloidogenic light chain induced cardiotoxicityStanniocalcin-1 regulates re-epithelialization in human keratinocytes.Human stanniocalcin-1 suppresses angiotensin II-induced superoxide generation in cardiomyocytes through UCP3-mediated anti-oxidant pathway.Human stanniocalcin-2 exhibits potent growth-suppressive properties in transgenic mice independently of growth hormone and IGFs.Mid-gestational gene expression profile in placenta and link to pregnancy complications.The stanniocalcin family of proteins.Stanniocalcin-1 Potently Inhibits the Proteolytic Activity of the Metalloproteinase Pregnancy-associated Plasma Protein-A.Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1.Functional and Transcriptional Characterization of Histone Deacetylase Inhibitor-Mediated Cardiac Adverse Effects in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes.Regulation of Intestinal Epithelial Calcium Transport Proteins by Stanniocalcin-1 in Caco2 Cells.Mammalian stanniocalcin-1 activates mitochondrial antioxidant pathways: new paradigms for regulation of macrophages and endotheliumHuman stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells.Circadian networks in human embryonic stem cell-derived cardiomyocytes.Stanniocalcin-1 attenuates ischemic cardiac injury and response of differentiating monocytes/macrophages to inflammatory stimuliStanniocalcin has deep evolutionary roots in eukaryotes.Stanniocalcin-1 in the subfornical organ inhibits the dipsogenic response to angiotensin II.Stanniocalcin-1, an inhibitor of macrophage chemotaxis and chemokinesis.Human stanniocalcin-1 or -2 expressed in mice reduces bone size and severely inhibits cranial intramembranous bone growth.Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart.Stanniocalcin 1 induction by thyroid hormone depends on thyroid hormone receptor β and phosphatidylinositol 3-kinase activation.Deduction of novel genes potentially involved in hypoxic AC16 human cardiomyocytes using next-generation sequencing and bioinformatics approaches
P2860
Q27331304-C4978F35-0B3A-4760-A777-4ED843B0FA0DQ28385588-98BB5B99-D660-4ADA-AE6E-873F0409E373Q28578322-C9EE0472-8DBE-4A83-9EE8-2C8E22782839Q30303109-575A0E19-219C-46E9-96B6-E6836F263B2EQ30570936-DC97F234-BBAB-4047-8996-A0D634C2AA13Q34070580-6BCE3616-462B-4E3E-9FEC-29BC3A57D06CQ34302283-E2CC5D6A-4F24-4A63-8138-C9802E292832Q34348245-1F6B8A8C-26E7-41AD-B2DF-723748A6100EQ34474307-AB8E77EE-883C-4A81-B54D-1923A708B49EQ34556479-2390F0D2-165D-4B4B-9811-BB6B73CB1635Q35701645-52D0274B-3824-42BA-AACD-049B7E10BF61Q36547021-30CD3BA2-F41F-4EBB-91AC-B7A8A98DEE99Q36808601-710EDCB2-E0E3-4363-83FC-0A3747F97822Q37134559-88A4F578-5C85-434A-B751-3222014EC7EDQ37175454-530FA1B4-2BE6-44B7-A076-110AD45F436CQ37317968-7376C2EE-6888-4932-83B0-7C82B53EF065Q38768295-E35BD18E-35B4-4AEE-B01C-A26DCBDC58DEQ39549057-0EEA746B-4A1C-4FF6-A58E-BF2C88D35605Q42641703-F035712B-1BFD-411B-AB3C-4D3EF67B6B73Q43712038-106313A6-1299-476F-847E-174AEADA2D51Q47431326-7104F62D-701E-4269-84D1-E6C410BABBD7Q47444302-44464DB6-3882-4F37-9137-18177B763EFAQ48134076-B437E0DE-0DEB-4566-AE1F-E17CF6329995Q49677526-294EFF9D-27D7-4FBE-BDA6-DC87A1C5B169Q58778577-3AAD0372-5F6D-40D2-BA65-13CC5A342BB0
P2860
Stanniocalcin-1 is a naturally occurring L-channel inhibitor in cardiomyocytes: relevance to human heart failure
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@ast
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@en
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@en-gb
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@nl
type
label
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@ast
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@en
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@en-gb
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@nl
prefLabel
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@ast
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@en
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@en-gb
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@nl
P2093
P2860
P921
P3181
P1476
Stanniocalcin-1 is a naturally ...... levance to human heart failure
@en
P2093
Ann Wamsley
Brian Poindexter
David Sheikh-Hamad
Gang-Yi Wu
Heinrich Taegtmeyer
Mark Entman
Peter Razeghi
Ranjit Padda
Roger Bick
Søren Nielsen
P2860
P304
P3181
P356
10.1152/AJPHEART.01071.2002
P407
P577
2003-03-27T00:00:00Z